📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Endocyte

1.1 - Company Overview

Endocyte Logo

Endocyte

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of receptor-targeted therapeutics for cancer and autoimmune/inflammatory diseases, including EC17, a folate-targeted hapten therapy for metastatic renal and ovarian cancer, and EC145, a folate-targeted chemotherapeutic conjugate for various tumors.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Endocyte

YM BioSciences Logo

YM BioSciences

HQ: Canada Website
  • Description: Provider of life sciences product development services focused on identifying and advancing a diverse portfolio of cancer-related products at various stages of development, leveraging regulatory and clinical trial expertise and a diversified business model to reduce risk while advancing clinical products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full YM BioSciences company profile →
TAE Life Sciences Logo

TAE Life Sciences

HQ: United States Website
  • Description: Provider of biologically targeted radiation therapy based on Boron Neutron Capture Therapy (BNCT), offering the Alphabeam compact hospital-use tandem accelerator neutron source, BNCT combining boron-10 drugs and neutron beams to selectively destroy cancer cells, and TC220, a boronated amino acid analog targeting cancers including GBM, breast, and melanoma; the only company with comprehensive target drug and neutron technology product.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TAE Life Sciences company profile →
Provision Healthcare Logo

Provision Healthcare

HQ: United States Website
  • Description: Provider of cancer care and proton therapy, offering the ProNova SC360 system (360° treatment with superconducting magnets), integrated dual-energy CBCT for IGRT, fast-scanning IMPT, an independent energy selection system for instantaneous room switching, SBRT, and ARC radiation therapy, with a focus on improving patient care, outcomes, research, education, and charitable causes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Provision Healthcare company profile →
OncoEthix Logo

OncoEthix

HQ: Switzerland Website
  • Description: Provider of cancer drug development, advancing a portfolio of three to five promising oncology compounds through clinical development; a private Swiss company founded in 2007.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OncoEthix company profile →
Fusion Pharmaceuticals Logo

Fusion Pharmaceuticals

HQ: Canada Website
  • Description: Provider of clinical-stage radiopharmaceuticals and targeted alpha therapies for oncology, leveraging deep radiochemistry and Fast-Clear Linker Technology to improve safety. Pipeline includes FPI-2265 targeting PSMA in prostate cancer (Phase 2), FPI-1434 targeting IGF-1R, and FPI-2059 targeting NTSR1. Offers manufacturing expertise to build commercial supply chains.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Fusion Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Endocyte

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Endocyte

2.2 - Growth funds investing in similar companies to Endocyte

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Endocyte

4.2 - Public trading comparable groups for Endocyte

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Endocyte

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Endocyte

What does Endocyte do?

Endocyte is a provider of receptor-targeted therapeutics for cancer and autoimmune/inflammatory diseases, including EC17, a folate-targeted hapten therapy for metastatic renal and ovarian cancer, and EC145, a folate-targeted chemotherapeutic conjugate for various tumors.

Who are Endocyte's competitors?

Endocyte's competitors and similar companies include YM BioSciences, TAE Life Sciences, Provision Healthcare, OncoEthix, and Fusion Pharmaceuticals.

Where is Endocyte headquartered?

Endocyte is headquartered in United States.

How many employees does Endocyte have?

Endocyte has 1,000 employees 🔒.

When was Endocyte founded?

Endocyte was founded in 2010 🔒.

What sector and industry vertical is Endocyte in?

Endocyte is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Endocyte

Who are the top strategic acquirers in Endocyte's sector and industry

Top strategic M&A buyers and acquirers in Endocyte's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Endocyte?

Top strategic M&A buyers groups and sectors for Endocyte include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Endocyte's sector and industry vertical

Which are the top PE firms investing in Endocyte's sector and industry vertical?

Top PE firms investing in Endocyte's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Endocyte's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Endocyte's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Endocyte's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Endocyte include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Endocyte's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Endocyte?

The key public trading comparables and valuation benchmarks for Endocyte include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Endocyte for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Endocyte with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Endocyte's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Endocyte with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Endocyte's' sector and industry vertical?

Access recent funding rounds and capital raises in Endocyte's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Endocyte